[{"NetIncomeLoss_1_Q2_USD":4415000.0,"ValuationAllowancesAndReservesChargedToCostAndExpense_2_Q2_USD":361984000.0,"InterestPaidNet_2_Q2_USD":1193000.0,"InventoryFinishedGoods_0_Q2_USD":65666000.0,"IncomeTaxesPaid_2_Q2_USD":20000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-396290000.0,"PurchaseObligation_0_Q2_USD":146000000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":-521000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":1359000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":151000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1809000.0,"AssetsCurrent_0_Q2_USD":827611000.0,"OperatingLeaseExpense_2_Q2_USD":800000.0,"OperatingLeaseExpense_1_Q2_USD":400000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"LongTermDebt_0_Q2_USD":22266000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":226332000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":92395000.0,"ContractWithCustomerLiability_0_Q2_USD":20213000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":63604000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":28797000.0,"TreasuryStockShares_0_Q2_shares":5741795.0,"AccountsReceivableGrossCurrent_0_Q2_USD":173186000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":352000.0,"TreasuryStockValue_0_Q2_USD":50252000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1776000.0,"CommonStockSharesIssued_0_Q2_shares":391589312.0,"Assets_0_Q2_USD":914869000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q2_shares":6989000.0,"LongTermDebtCurrent_0_Q2_USD":22455000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":27925000.0,"PreferredStockSharesOutstanding_0_Q2_shares":51603780.0,"OperatingLeaseLiability_0_Q2_USD":10400000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":390000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":20247000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":9969000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":18223000.0,"OtherLongTermDebt_0_Q2_USD":0.0,"InventoryRawMaterials_0_Q2_USD":29122000.0,"ValuationAllowancesAndReservesDeductions_2_Q2_USD":206059000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":5543000.0,"EarningsPerShareBasic_1_Q2_USD":0.01,"EarningsPerShareBasic_2_Q2_USD":-0.04,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":399664000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":373300000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":17000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":108000.0,"AccountsReceivableNetCurrent_0_Q2_USD":124985000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-2359000.0,"CommonStockValue_0_Q2_USD":285672000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":-238000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-40009000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_2_Q2_USD":65530000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":238000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":131440000.0,"IncreaseDecreaseInInventories_2_Q2_USD":48075000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":720000.0,"OtherAssetsNoncurrent_0_Q2_USD":1074000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":214007000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9311000.0,"Liabilities_0_Q2_USD":312106000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":1159000.0,"ShareBasedCompensation_2_Q2_USD":22722000.0,"ShortTermInvestments_0_Q2_USD":336273000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8291000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":848000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":1097000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":4382000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_2_Q2_USD":1312000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-18497000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":4415000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":14352000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":12131000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":5724000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":384663000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":373300000.0,"InventoryWorkInProcess_0_Q2_USD":30056000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1495000.0,"LiabilitiesCurrent_0_Q2_USD":283467000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":527479000.0,"AccountsPayableCurrent_0_Q2_USD":86757000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1658000.0,"GrossProfit_2_Q2_USD":226706000.0,"GrossProfit_1_Q2_USD":106520000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.115,"AdditionalPaidInCapital_0_Q2_USD":1787492000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":217920000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":560755.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":848000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":14538000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":51603780.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2316000.0,"NetIncomeLoss_2_Q2_USD":-16138000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":23589000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.04,"EarningsPerShareDiluted_1_Q2_USD":0.01,"CommonStockSharesOutstanding_0_Q2_shares":385847517.0,"CommonStockParOrStatedValuePerShare_0_Q2_GBP":0.5,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":7811000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1843000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":10273000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":290310000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":135317000.0,"OperatingIncomeLoss_2_Q2_USD":-19873000.0,"OperatingIncomeLoss_1_Q2_USD":4156000.0,"InventoryNet_0_Q2_USD":124844000.0,"IncreaseDecreaseInInterestPayableNet_2_Q2_USD":-240000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":5706000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":20081000.0,"PreferredStockValue_0_Q2_USD":7166000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":914869000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1101000.0,"OperatingExpenses_2_Q2_USD":246579000.0,"OperatingExpenses_1_Q2_USD":102364000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":3913000.0,"ProfitLoss_2_Q2_USD":-16138000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4821000.0,"StockholdersEquity_0_Q2_USD":602763000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":14507000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":251000.0,"LongTermInvestments_0_Q2_USD":61039000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-33000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":490000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1427315000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-430575000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":8555000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_GBP":0.05,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-633000.0,"Ticker":"AMRN","CIK":"897448","name":"AMARIN CORP PLCUK","OfficialName":"Amarin Corporation plc","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1265593617.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]